Help with healthcare costs for metastatic melanoma
This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. Check your eligibility with our quick and easy tools below. If this fund is open, apply today for an instant approval decision and use your grant funding right away. Learn how TotalAssist helps you.
TotalAssist also offers a melanoma fund. Please note that you cannot receive more than one grant for the same condition.
Eligibility criteria
To be eligible for this fund, you must:
- Have a confirmed diagnosis and are in treatment for metastatic melanoma, or planning to begin treatment in the next 60 days, or have been in treatment in the past 6 months. This includes active surveillance of a condition
- Have government-insured coverage that covers your qualifying expenses
- Have an income at or less than 500% of the Federal Poverty Level, adjusted for your regional Cost of Living Index (COLI). What is this?
- Be a legal resident and receive treatment in the U.S. or a U.S. territory
- Be prescribed a medication or product listed in the approved medications, listed below
Quick eligibility checker
- Treatment
- Insurance
- Income
Approved medications
Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines.
- Abraxane (Paclitaxel Protein-Bound)
- Alkeran (Melphalan Hydrochloride)
- Amtagvi (Lifileucel)
- Braftovi (Encorafenib)
- Carboplatin (Carboplatin)
- Cotellic (Cobimetinib Fumarate)
- Dacarbazine (Dacarbazine)
- Gleevec (Imatinib Mesylate)
- Hepzato (Melphalan Hydrochloride)
- Imatinib Mesylate (Imatinib Mesylate)
- Imiquimod (Imiquimod)
- Imkeldi (Imatinib Mesylate)
- Imlygic (Talimogene Laherparepvec)
- IVRA (Melphalan)
- Keytruda (Pembrolizumab)
- KEYTRUDA QLEX (Pembrolizumab-Berahyaluron-Pmph)
- Kimmtrak (Tebentafusp-Tebn)
- Mekinist (Trametinib)
- Mektovi (Binimetinib)
- Opdivo (Nivolumab)
- OPDIVO QVANTIG (Nivolumab-Hyaluronidase-Nvhy)
- OPDUALAG (Nivolumab-Relatlimab-Rmbw)
- Paclitaxel (Paclitaxel)
- Paclitaxel Protein-Bound (Paclitaxel Protein-Bound)
- Paraplatin (Carboplatin)
- Proleukin (Aldesleukin)
- Rozlytrek (Entrectinib)
- Tafinlar (Dabrafenib Mesylate)
- Tecentriq (Atezolizumab)
- Tecentriq Hybreza (Atezolizumab-Hyaluronidas-Tqjs)
- Temodar (Temozolomide)
- Temozolomide (Temozolomide)
- Vitrakvi (Larotrectinib)
- Yervoy (Ipilimumab)
- Zelboraf (Vemurafenib)
About the disease
Metastatic melanoma, Stage IV melanoma, is a serious form of skin cancer that has spread from the skin to other parts of the body, such as the lungs, liver, brain, or bones. It begins in pigment-producing skin cells called melanocytes and can spread if not treated early. Symptoms depend on where the cancer has spread, but may include new lumps, pain, headaches, trouble breathing, or extreme tiredness.
Diagnosis codes
C43, C43.0, C43.1, C43.10, C43.11, C43.111, C43.112, C43.12, C43.121, C43.122, C43.2, C43.20, C43.21, C43.22, C43.3, C43.30, C43.31, C43.39,
C43.4, C43.5, C43.51, C43.52, C43.59, C43.6, C43.60, C43.61, C43.62, C43.7, C43.70, C43.71, C43.72, C43.8, C43.9, C69.3, C69.30, C69.31, C69.32
How to apply
-
If your fund is open, apply online 24/7, or call 866-512-3861, Monday – Friday, 8:30am – 5:30pm ET.
-
Answer pre-screening questions to confirm eligibility. Have your income, medication, diagnosis, and insurance information ready.
-
Complete the application and get an instant approval decision. You can begin using your grant right away.
Application guides
Questions?
Search help articles
Find answers to your questions about applying, claims, grant use, and your portal account.
Search help
How does it work?
You can use your TotalAssist grant award to help pay for out-of-pocket healthcare expenses.
Learn more
Need help applying?
Call us at 866-512-3861 to apply by phone, Monday through Friday, 8:30am - 5:30pm ET.
Contact usRelated organizations
Connect with other organizations and resources for support.
Featured partner:
The Melanoma Research Foundation (MRF) supports patients and caregivers through education, resources, and advocacy, while funding and advancing research to improve treatments and work toward a cure. The MRF also raises awareness and provides trusted information on prevention, diagnosis, and care.
Get support
Explore resources beyond TotalAssist
Patient Advocate Foundation knows that patients may need support, information, and resources beyond TotalAssist. This can include services like case management, help with living expenses, and much more. Search our National Financial Resources Directory, find community specific resources, and explore our patient education library.
Find resources